SPX -0.95% VIX -2.46%
STOCKS SET TO SNAP BACK AS MNUCHIN SAYS U.S. WAS 90% OF THE WAY THERE ON CHINA 
ROBERT MUELLER AGREES TO TESTIFY BEFORE HOUSE COMMITTEES ON JULY 17 
MICRON STOCK RISES 4% AS EARNINGS BEAT LOWERED BAR 
NASDAQ DROPS 1.5%, LEADING BENCHMARKS LOWER, AS FED DAMPENS RATE-CUT ENTHUSIASM 
STOCK MARKET HITS INTRADAY LOWS AS FED'S BULLARD DOWNPLAYS 'HUGE ACTION' IN JULY 
CONSUMER CONFIDENCE FALLS TO LOWEST LEVEL IN 21 MONTHS; NEW-HOME SALES FALTER 
STOCKS OPEN STEADY; POWELL'S SPEECH IN FOCUS 
ANNUAL HOME-PRICE GAINS SLOW FOR 13TH STRAIGHT MONTH: CASE-SHILLER 
10-YEAR TREASURY YIELD DIPS BELOW 2% 
NEED TO KNOW: FORGET THE PREDICTIONS FOR RECESSION, WE'RE ALREADY THERE 
Wed, Jun 26 7:59am

Compare ACST



Acasti Pharma, Inc. - Class A Common Stock [ACST]
$1.05 0.04 (3.96%)

ACST Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 80 Million
ACST Description

Acasti Pharma Inc is a biopharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. The key product candidate of the company, CaPre is developed for the treatment of severe hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. The company operates through the single segment being Development and commercialization of prescription drugs.


Visit Website

ACST Earnings

EPS -0.07 P/E Ratio 0.00
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Wed, Jun 26, 2019 Today

ACST Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACST Charts

$0.45
52 Week Range
$1.57
Aug 16, 2018
Oct 1, 2018



Symbol Price Day % YTD %
ACST $1.05 3.96% 16.67%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy